TCT 1424: Transcatheter Aortic Valve Replacement (TAVR) With JenaValve Trilogy System for Aortic Regurgitation Following a David Procedure
We Recommend
Disclosures
<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Terumo Medical Corporation; Biotronik; Boston Scientific Corporation</li></ul>